Implexis
PrivateLast Round
Seed
Jun 15, 2026
Total Funding Raised
$330,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Implexis is a biotechnology company that provides a proprietary platform to accelerate drug formulation development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Vertical SaaS, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Implexis Comparables
Compare Implexis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Persist AI | 80% | |
| Intrepid Labs | 79% | |
| VeriSIM Life | 77% |
Implexis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 15, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2026
$330K raised in Seed round.
Implexis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Implexis's valuation, stock price, and market status.
Is Implexis a public or private company?
Implexis is a private company.
What is the current stock price of Implexis?
Implexis is a private company with no public stock price. Caplight tracks Implexis's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Implexis worth (valuation)?
Valuation information for Implexis is not publicly available.
Can I buy Implexis stock?
Implexis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Implexis's last funding round?
Implexis's most recent funding round was Seed on June 15, 2026.
Who are the main investors in Implexis?
Investor information for Implexis is not publicly disclosed.
Will Implexis IPO soon?
No public IPO plans have been announced for Implexis.
How can I track Implexis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Implexis's secondary market activity and sign up for updates.